Core Insights - IQVIA Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and clinical research services for the life sciences industry, headquartered in Durham, North Carolina [1] - The company has a market capitalization of $41.28 billion and operates across several countries, assisting pharmaceutical, biotechnology, and medical device companies through its core segments [2] Financial Performance - Analysts expect IQVIA to report a profit of $3.13 per share on a diluted basis for Q4 fiscal 2025, representing a year-over-year increase of 7.9% [4] - For the full fiscal year 2025, diluted EPS is expected to grow by 5.3% annually to $10.79, followed by an 8.7% improvement to $11.73 in fiscal 2026 [4] Stock Performance - Over the past 52 weeks, IQVIA's stock has gained 18.5%, while over the past six months, it has gained 48% [5] - In comparison, the broader S&P 500 Index has increased by 19.7% and 11.5% over the same periods, indicating that IQVIA has underperformed the broader market over the past year but outperformed over the past six months [5] Sector Comparison - The State Street Health Care Select Sector SPDR ETF has gained 12.7% over the past 52 weeks and 16.4% over the past six months, showing that IQVIA has outperformed its sector during these periods [6] Strategic Partnerships - Last month, IQVIA announced a partnership with Amazon Web Services (AWS), designating AWS as its Preferred Agentic Cloud Provider, which includes the provision of IQVIA's AI platform on AWS to enhance healthcare analytics [7]